BioSpace News Archive

Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced that it and its investigator sponsors will present four new abstracts at the virtual American Society of Clinical Oncology (ASCO) Annual Meeting from June 4 – June 8, 2021 and five abstracts at the virtual 26th Annual Congress of the European Hematology Association (EHA2021) from June 9 –16, 2021.

Newron Pharmaceuticals S.p.A. today announced that with reference to its media release of May 4, 2021, it received further Paragraph IV Notice Letters regarding the submission by a generic manufacturer of an Abbreviated New Drug Application to the U.S. Food and Drug Administration

Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today reported on positive results presented in two separate posters in conjunction with ACTHIV 2021 virtual conference being held May 20-22, 2021.

Zealand Pharma A/S, a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 2,000 divided into 2,000 new shares with a nominal value of DKK 1 each.

On May 19, 2021, 2,562,375 shares were issued out of the existing authorized capital as treasury shares.

PRIMROSE 1 76-week results confirmPRIMROSE 2 data showing sustained post-treatment effects and evidence of bone mineral density (BMD) recovery following 52 weeks of treatment

BI 765063, a first-in-class SIRPα inhibitor on the SIRPα/CD47 “Don’t eat me” pathway, is undercollaborative development with Boehringer Ingelheim.

Nordic Nanovector ASA announces that it will report its results for the first quarter 2021 on Wednesday, 26 May 2021.

Multiparameter patient monitoring market is expected to remain under the influence of increasing demographic of an ageing population, increasing adoption of advanced technologies in the healthcare sector and increasing emphasis on improving critical patient care settings.

The vendor landscape of the global market of hematology diagnostics features a handful of companies collectively accounting for a large share in the overall market, hinting at a largely consolidated vendor landscape, observes Transparency Market Research in a recent report.